Bioabsorbable polymer‐coated sirolimus‐eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub‐study

Publisher： John Wiley & Sons Inc

E-ISSN： 1522-726x|86|7|1141-1150

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.86, Iss.7, 2015-12, pp. : 1141-1150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The real world experience of the biodegradable polymer‐coated sirolimus‐eluting coronary stent system

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 88, Iss. 3, 2016-09 ,pp. : E93-E98

John Wiley & Sons Inc

Access to resources Recommend Favorite

Noninvasive Evaluation of Coronary Endothelial Function following Sirolimus-Eluting Stent Implantation by Using Positron Emission Tomography

By  

Cardiology, Vol. 114, Iss. 3, 2009-06 ,pp. : 157-163

Karger

Access to resources Recommend Favorite

The Supralimus ® sirolimus-eluting stent

By Lemos Pedro A   Bienert Igor  

Expert Review of Medical Devices, Vol. 10, Iss. 3, 2013-05 ,pp. : 295-300

Informa Healthcare

Access to resources Recommend Favorite

First‐in‐man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus‐eluting stent in the treatment of patients with de novo coronary lesions: Clinical, Angiographic, and OCT outcomes of CREDIT‐1

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. S1, 2015-03 ,pp. : 744-751

John Wiley & Sons Inc

Access to resources Recommend Favorite

Five‐year clinical follow‐up of a randomized comparison of a polymer‐free sirolimus‐eluting stent versus a polymer‐based paclitaxel‐eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial)

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 83, Iss. 3, 2014-02 ,pp. : 418-424

John Wiley & Sons Inc

Access to resources Recommend Favorite